Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation
- 15 December 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (24), 10205-10214
- https://doi.org/10.1158/0008-5472.can-08-2149
Abstract
There are currently no effective therapies for metastatic melanoma and targeted immunotherapy results in the remission of only a very small percentage of tumors. In this study, we show that the noncanonical Wnt ligand, Wnt5A, can increase melanoma metastasis in vivo while down-regulating the expression of tumor-associated antigens important in eliciting CTL responses (e.g., MART-1, GP100, and tyrosinase). Melanosomal antigen expression is governed by MITF, PAX3, and SOX10 and is inhibited upon signal transducers and activators of transcription 3 (STAT3) activation, via decreases in PAX3 and subsequently MITF expression. Increasing Wnt5A in Wnt5A-low cells activated STAT3, and STAT3 was decreased upon Wnt5A knockdown. Downstream targets such as PAX3, MITF, and MART-1 were also affected by Wnt5A treatment or knockdown. Staining of a melanoma tissue array also highlighted the inverse relationship between MART-1 and Wnt5A expression. PKC activation by phorbol ester mimicked Wnt5A effects, and Wnt5A treatment in the presence of STAT3 or PKC inhibitors did not lower MART-1 levels. CTL activation studies showed that increases in Wnt5A correspond to decreased CTL activation and vice versa, suggesting that targeting Wnt5A before immunotherapy may lead to the enhancement of current targeted immunotherapy for patients with metastatic melanoma. [Cancer Res 2008;68(24):10205–14]Keywords
Other Versions
This publication has 37 references indexed in Scilit:
- Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Cell Cycle, 2006
- Activation of Stat3 in Human Melanoma Promotes Brain MetastasisCancer Research, 2006
- Genetics of pigment cells: lessons from the tyrosinase gene family2006
- The role of protein kinase C δ activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferationJournal of Cell Science, 2006
- High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA ElectroporationMolecular Therapy, 2006
- Engineering T cells for cancer therapyBritish Journal of Cancer, 2005
- Expression of melan-a/MART-1 antigen as a prognostic factor in primary cutaneous melanomaInternational Journal of Cancer, 2001
- Ca2+/Calmodulin-dependent Protein Kinase II Is Stimulated by Wnt and Frizzled Homologs and Promotes Ventral Cell Fates in XenopusPublished by Elsevier BV ,2000
- Mass‐spectrometric evaluation of HLA‐A*0201‐associated peptides identifies dominant naturally processed forms of CTL epitopes from MART‐1 and gp100International Journal of Cancer, 1999
- Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in aG-protein-dependent mannerCurrent Biology, 1999